626012950	626012950	CD	B-NP	O
|	|	NN	I-NP	O
HCHO	HCHO	NN	I-NP	O
|	|	NN	I-NP	O
41614963	41614963	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
997390	997390	CD	B-NP	O
|	|	CC	I-NP	O
10/18/1999	10/18/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/20/1999	4/20/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/11/1999	6/11/1999	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ATRIAL	ATRIAL	NN	B-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
POST	POST	NN	I-NP	O
CARDIOVERSION	CARDIOVERSION	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
38-year-old	38-year-old	JJ	I-NP	O
African	African	JJ	I-NP	O
American	American	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
familial	familial	JJ	I-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
20	20	CD	I-NP	O
percent	percent	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
AICD	AICD	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recurrent	recurrent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
two	two	CD	B-NP	O
prior	prior	JJ	I-NP	O
attempts	attempt	NNS	I-NP	O
at	at	IN	B-PP	O
cardioversion	cardioversion	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
also	also	RB	I-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
for	for	IN	B-PP	O
chemical	chemical	JJ	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
severe	severe	JJ	B-NP	O
hyperthyroidism	hyperthyroidism	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
several	several	JJ	B-NP	O
recent	recent	JJ	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
exacerbations	exacerbation	NNS	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
recently	recently	RB	I-ADVP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
1998	1998	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
tailored	tailor	VBN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
20	20	CD	B-NP	O
percent	percent	NN	I-NP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
dimension	dimension	NN	I-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
diastolic	diastolic	JJ	I-NP	O
dimension	dimension	NN	I-NP	O
of	of	IN	B-PP	O
7.7	7.7	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
,	,	,	O	O
moderate-severe	moderate-severe	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
,	,	,	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
diuresed	diurese	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
186	186	CD	I-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
with	with	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
cardioverted	cardioverte	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
previously	previously	RB	I-NP	O
implanted	implant	VBN	I-NP	O
AICD	AICD	NNP	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
to	to	TO	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
again	again	RB	B-ADVP	O
was	be	VBD	B-VP	O
cardioverted	cardioverte	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
AICD	AICD	NN	I-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1999	1999	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
firing	firing	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
AICD	AICD	NNP	I-NP	O
both	both	CC	B-PP	O
for	for	IN	B-PP	O
true	true	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
anti-tachycardia	anti-tachycardia	JJ	B-NP	O
pacing	pacing	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
clinic	clinic	NN	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
207	207	CD	B-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
199	199	CD	B-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
amiodarone	amiodarone	NN	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
drug	drug	NN	I-NP	O
for	for	IN	B-PP	O
him	him	PRP	B-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
ventricular	ventricular	JJ	I-NP	O
and	and	CC	I-NP	O
atrial	atrial	JJ	I-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
elective	elective	JJ	I-NP	O
thyroid	thyroid	NN	I-NP	O
ablation	ablation	NN	I-NP	O
with	with	IN	B-PP	O
radioactive	radioactive	JJ	B-NP	O
iodine	iodine	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
30	30	CD	B-NP	O
mCi	mCi	NN	I-NP	O
of	of	IN	B-PP	O
I-131	I-131	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
now	now	RB	B-ADVP	O
presents	present	VBZ	B-VP	O
today	today	NN	B-NP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
thyroid	thyroid	JJ	I-NP	O
ablation	ablation	NN	I-NP	O
for	for	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
load	load	NN	I-NP	O
and	and	CC	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
feeling	feel	VBG	I-VP	O
relatively	relatively	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
experiencing	experience	VBG	I-VP	O
any	any	DT	B-NP	O
significant	significant	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
or	or	CC	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
reports	report	VBZ	B-VP	O
no	no	DT	B-NP	O
increased	increase	VBN	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
neck	neck	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NNP	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Notable	Notable	NNP	I-NP	O
for	for	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
V.	V.	NNP	I-NP	O
02	02	CD	I-NP	O
is	be	VBZ	B-VP	O
19.5	19.5	CD	B-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1995	1995	CD	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
AICD	AICD	NN	I-NP	O
placement	placement	NN	I-NP	O
for	for	IN	B-PP	O
ventricular	ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Hyperthyroidism	Hyperthyroidism	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
cardioversions	cardioversion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
see	see	VBP	B-VP	O
above	above	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
pancreatis	pancreatis	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Captopril	Captopril	NNP	I-NP	I-protein
75	75	CD	I-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
q.i.d.	q.i.d.	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
Digoxin	Digoxin	NN	I-NP	I-protein
0.125	0.125	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
q.d.	q.d.	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
Isordil	Isordil	NN	I-NP	I-protein
40	40	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Torsemide	Torsemide	NN	I-NP	I-protein
200	200	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
5	5	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
q.d.	q.d.	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
6	6	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Prilosec	Prilosec	NNP	I-NP	O
20	20	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
-LRB-	-LRB-	SYM	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Zaroxolyn	Zaroxolyn	NNP	I-NP	O
p.r.n.	p.r.n.	NNP	I-NP	O
SOCIAL	SOCIAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Notable	Notable	NNP	B-NP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
father	father	NN	I-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
56	56	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
brother	brother	NN	I-NP	O
with	with	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
who	who	WP	B-NP	O
died	die	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
50s	50	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
another	another	DT	B-NP	O
brother	brother	NN	I-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
.	.	.	O	O

VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Pulse	Pulse	NN	B-NP	O
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
90/75	90/75	CD	B-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
regular	regular	JJ	B-ADJP	O
,	,	,	O	O
irregular	irregular	JJ	B-ADJP	O
with	with	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
intermittent	intermittent	JJ	B-NP	O
S3	S3	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
II/VI	II/VI	NN	I-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
best	well	RBS	B-VP	O
auscultated	auscultate	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
axilla	axilla	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
belly	belly	NN	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
palpable	palpable	JJ	I-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
1.5	1.5	CD	B-NP	O
centimeters	centimeter	NNS	I-NP	O
below	below	IN	B-PP	O
the	the	DT	B-NP	O
costal	costal	JJ	I-NP	O
margin	margin	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
pulsatile	pulsatile	JJ	B-ADJP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Distal	Distal	JJ	B-NP	O
Pulses	Pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
58	58	CD	B-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.5	2.5	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
of	of	IN	B-PP	O
3.8	3.8	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
5.1	5.1	CD	B-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
42.8	42.8	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
8.5	8.5	CD	B-NP	O
.	.	.	O	O

DIAGNOSTIC	DIAGNOSTIC	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
electrocardiogram	electrocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
of	of	IN	B-PP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
120	120	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
zero	zero	CD	I-NP	O
degree	degree	NN	I-NP	O
axis	axis	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
intraventricular	intraventricular	JJ	I-NP	O
conduction	conduction	NN	I-NP	O
delay	delay	NN	I-NP	O
;	;	:	O	O
R-wave	R-wave	NN	B-NP	O
progression	progression	NN	I-NP	O
was	be	VBD	B-VP	O
poor	poor	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
ST-T	ST-T	JJ	B-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
digitalis	digitalis	NN	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
cardiogram	cardiogram	NN	I-NP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
at	at	IN	B-PP	O
400	400	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Endocrinologist	Endocrinologist	NNP	B-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
followed	follow	VBN	B-VP	O
along	along	IN	B-PP	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
his	his	PRP$	B-NP	O
ablation	ablation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
and	and	CC	O	O
slightly	slightly	RB	B-ADJP	O
hypovolemic	hypovolemic	JJ	I-ADJP	O
upon	upon	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
diuretics	diuretic	NNS	I-NP	O
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
Torsemide	Torsemide	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
approximately	approximately	RB	B-NP	O
36	36	CD	I-NP	O
hours	hour	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
liberalization	liberalization	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
normalized	normalize	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
became	become	VBD	B-VP	O
slight	slight	JJ	B-ADJP	O
hypervolemic	hypervolemic	JJ	I-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
diuretic	diuretic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
was	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
twice	twice	RB	I-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
extra	extra	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
Torsemide	Torsemide	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
third	third	JJ	I-NP	O
of	of	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
March	March	NNP	B-NP	O
,	,	,	O	O
1999	1999	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
cardioverted	cardioverte	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
ICD	ICD	NN	I-NP	B-protein
with	with	IN	B-PP	O
30	30	CD	B-NP	O
joules	joule	NNS	I-NP	O
of	of	IN	B-PP	O
synchronous	synchronous	JJ	B-NP	O
shock	shock	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
turned	turn	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
at	at	IN	B-PP	O
400	400	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
nauseated	nauseate	VBN	I-ADJP	O
with	with	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
vomiting	vomit	VBG	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
some	some	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
inotropic	inotropic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
intermittently	intermittently	RB	I-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
,	,	,	O	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
quite	quite	RB	B-ADJP	O
unwell	unwell	JJ	I-ADJP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
,	,	,	O	O
feeling	feel	VBG	B-VP	O
nauseated	nauseate	VBN	B-ADJP	O
and	and	CC	O	O
relatively	relatively	RB	B-ADJP	O
hypertensive	hypertensive	JJ	I-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medicines	medicine	NNS	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
cardioverted	cardioverte	VBN	I-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
now	now	RB	B-ADVP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
load	load	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
completed	complete	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
thyroid	thyroid	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
subsequent	subsequent	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
ablation	ablation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
T4	T4	NN	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
9.6	9.6	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
thyroid	thyroid	JJ	I-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
rechecked	rechecke	VBN	B-VP	O
in	in	IN	B-PP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
endocrine	endocrine	JJ	I-NP	O
clinic	clinic	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
initiate	initiate	VB	I-VP	O
therapy	therapy	NN	B-NP	O
with	with	IN	B-PP	O
Tapazole	Tapazole	NN	B-NP	O
10	10	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
protect	protect	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
from	from	IN	B-PP	O
developing	develop	VBG	B-VP	O
hyperthyroidism	hyperthyroidism	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
as	as	IN	B-PP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
had	have	VBD	B-VP	O
fallen	fall	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
3.0	3.0	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	B-protein
team	team	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
admission	admission	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
slightly	slightly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
pre-renal	pre-renal	JJ	B-NP	O
dehydration	dehydration	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
is	be	VBZ	B-VP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
1.6	1.6	CD	B-NP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
forward	forward	JJ	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Captopril	Captopril	NNP	I-NP	I-protein
75	75	CD	I-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
q.i.d.	q.i.d.	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
Digoxin	Digoxin	NN	I-NP	I-protein
0.125	0.125	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
q.d.	q.d.	VBN	B-VP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	I-NP	I-protein
Isordil	Isordil	NN	I-NP	I-protein
40	40	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
4	4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Amiodarone	Amiodarone	NN	I-NP	I-protein
200	200	CD	B-NP	I-protein
milligrams	milligram	NNS	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Torsemide	Torsemide	NN	I-NP	O
200	200	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
-LRB-	-LRB-	HYPH	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Prilosec	Prilosec	NNP	I-NP	O
20	20	CD	I-NP	O
milligrams	milligram	NNS	I-NP	O
bid	bid	VBD	B-VP	O
-LRB-	-LRB-	SYM	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Tapazole	Tapazole	NN	I-NP	O
10	10	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
q.d.	q.d.	VBN	B-VP	O
to	to	TO	I-VP	O
begin	begin	VB	I-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
8	8	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
K-Dur	K-Dur	NNP	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
9	9	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
3	3	CD	B-NP	O
milligrams	milligram	NNS	I-NP	O
q.d.	q.d.	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

FOLLOW	FOLLOW	JJ	B-NP	O
UP	UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Mowe	Mowe	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
early	early	JJ	B-NP	O
next	next	JJ	I-NP	O
week	week	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
return	return	VB	I-VP	O
in	in	IN	B-PP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
,	,	,	O	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
thyroid	thyroid	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
checked	check	VBD	B-VP	O
,	,	,	O	O
as	as	RB	O	O
previously	previously	RB	B-ADVP	O
stated	state	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointments	appointment	NNS	B-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
endocrine	endocrine	JJ	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
close	close	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
transplant	transplant	NN	I-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ROLAND	ROLAND	NNP	B-NP	O
JONAH	JONAH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AI86	AI86	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GROVER	GROVER	NNP	B-NP	O
L.	L.	NNP	I-NP	O
SPERO	SPERO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD2	AD2	NNP	I-NP	O
OS225/1985	OS225/1985	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
23246	23246	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

QOURMC17Z6	QOURMC17Z6	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
7/23/99	7/23/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/23/99	7/23/99	CD	B-NP	O

